Subscribe

Image – Interventional flashlight

DOI: 10.4244/EIJ-D-19-00826

ACURATE neo valve perforation after valve-in-valve transcatheter aortic valve implantation

Andreas Rück1, MD, PhD; Magnus Settergren1, MD, PhD; Nawzad Saleh1, MD, PhD; Dinos Verouhis1, MD, PhD

Figure 1. Possible cause of perforated ACURATE neo valve. A) Fluoroscopy after valve-in-valve TAVI using the ACURATE neo inside a Biocor surgical bioprosthesis. Red arrow showing the same area as in panels B and C. B) Ex vivo image showing (red arrow) proximity of the upper edge of the stent post of the Biocor (outside) and the ACURATE neo prosthesis. Image courtesy of Dr Vinayat Bapat and UBQO Limited, London, UK. C) The explanted ACURATE neo, with a hole under the stent post between the right and left cusps (red arrow).

In 2001, a 61-year-old male was operated and a 25 mm Biocor™ (St. Jude Medical, St. Paul, MN, USA) aortic bioprosthesis was implanted. In 2017, the patient developed dyspnoea. Echocardiography revealed severe transvalvular regurgitation.

In January 2018, a transcatheter aortic valve implantation (TAVI) valve-in-valve procedure was performed using a 23 mm ACURATE neo™ prosthesis (Boston Scientific, Marlborough, MA, USA) (Figure 1A). The prosthesis was post-dilated with a 22 mm balloon. Postoperative and 30-day echocardiography was unremarkable.

In August 2018, the patient reported exertional dyspnoea. Echocardiography showed severe paravalvular and transvalvular aortic regurgitation. There were no signs of infection. Both prostheses were explanted and a PERIMOUNT Magna Ease 23 mm bioprosthesis (Edwards Lifesciences, Irvine, CA, USA) was successfully implanted. Recovery was uneventful.

The ACURATE neo TAVI prosthesis has a triangular area under each stent post which is covered with porcine pericardium but not protected by metal, possibly a weak spot. It was noticed that the stent posts of the Biocor prosthesis and the ACURATE neo were aligned (Figure 1B), putting the weak spot in contact with the top of the surgical bioprosthesis’ stent posts, and causing a hole at this location by abrasion (Figure 1C).

This mechanism of prosthesis failure may indicate that the ACURATE neo prosthesis should be used with caution in valve-in-valve procedures (Moving image 1),1.

Conflict of interest statement

A. Rück has received lecture honoraria, research support and proctor fees from Boston Scientific and Edwards Lifesciences. M. Settergren has received lecture honoraria and proctor fees from Abbott, Boston Scientific, Medtronic, W.L. Gore and Edwards Lifesciences. N. Saleh has received lecture honoraria and proctor fees from Boston Scientific. The other author has no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Location of the perforation in the ACURATE neo prosthesis in the weak spot just below the stent post.

Volume 16 Number 7
Sep 18, 2020
Volume 16 Number 7
View full issue


Key metrics

Suggested by Cory

Research correspondence

10.4244/EIJ-D-22-00740 Apr 24, 2023
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis
Vanhaverbeke M et al
free

EXPERT REVIEW

10.4244/EIJ-D-18-00667 Sep 7, 2018
Novel strategies in aortic valve-in-valve therapy including bioprosthetic valve fracture and BASILICA
Dvir D et al
free

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free

10.4244/EIJV7I1A25 May 17, 2011
How should I treat acute valve regurgitation?
Schultz C et al
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA8 Sep 18, 2016
Late degeneration of transcatheter aortic valves: pathogenesis and management
Barbanti M and Tamburino C
free
Trending articles
69.996

10.4244/EIJV13I12A217 Dec 8, 2017
Swimming against the tide: insights from the ORBITA trial
Al-Lamee R and Francis D
free
59.65

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
57.6

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
38.75

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
15.85

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
Why is the area under the stent posts a weak point?
How can failures like this be prevented in the future?
What led to examination of the explanted valves?
What further evaluations may provide additional insights?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved